{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:31:10Z","timestamp":1790087470440,"version":"4.0.1"},"reference-count":81,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Des Moines University","award":["IOER 112\u20133119"],"award-info":[{"award-number":["IOER 112\u20133119"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Bladder cancer is among the most common form of cancer worldwide and is predicted to increase in incidence and mortality over the next decade. Squamous cell carcinoma of the bladder is a rare histological variant typically associated with schistosomiasis, also known as bilharzia, a parasitic infection caused by flatworms called schistosomes or blood flukes, and is generally seen in underdeveloped nations. However, squamous cell carcinoma of the bladder still represents nearly 5% of bladder cancer diagnoses in the western world. Transitional cell carcinoma is the predominant histological variant of bladder cancer found throughout the western world, and nearly all disease indicators and treatments for bladder cancer are driven by this common variant. Squamous cell carcinoma of the bladder shows characteristic features that differ from transitional cell carcinoma, such as differing levels of protein indicators and different response rates to traditional bladder cancer therapies. Common treatment methods for squamous cell carcinoma of the bladder include radical cystectomy, chemotherapies, and radiation. Reviewing the previous literature on the management of squamous cell carcinoma of the bladder, it becomes apparent that this variant needs to be treated differently than common bladder cancer variants and a proper management course needs to be set in place to maximize positive patient outcomes. Such a study will be very helpful for urologists and oncologists to manage patients with bladder squamous cell carcinoma.<\/jats:p>","DOI":"10.3390\/cancers17020169","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:06:34Z","timestamp":1736226394000},"page":"169","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Squamous Cell Bladder Cancer: A Rare Histological Variant with a Demand for Modern Cancer Therapeutics"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1443-1512","authenticated-orcid":false,"given":"Scott D.","family":"Bell","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-4566","authenticated-orcid":false,"given":"Anthony E.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Bajo","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton G.","family":"Mayberry","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, USA"},{"name":"Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braydon C.","family":"Cowan","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, USA"},{"name":"Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"Marrah","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, USA"},{"name":"Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-7895","authenticated-orcid":false,"given":"Mark R.","family":"Wakefield","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, USA"},{"name":"Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiang","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA"},{"name":"Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, USA"},{"name":"Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J. Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: A systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","article-title":"What Is the Significance of Variant Histology in Urothelial Carcinoma?","volume":"6","author":"Lobo","year":"2020","journal-title":"Eur. Urol. Focus."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","article-title":"Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0022-5347(17)59272-1","article-title":"Squamous cell carcinoma of the bladder","volume":"115","author":"Johnson","year":"1976","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/PAS.0b013e31805c9cd9","article-title":"Squamous Cell Carcinoma of the Bladder: A Clinicopathologic Analysis of 45 Cases","volume":"31","author":"Lagwinski","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0090-4295(84)90035-9","article-title":"Squamous cell carcinoma of bladder","volume":"23","author":"Costello","year":"1984","journal-title":"Urology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/cncr.22853","article-title":"Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: A contemporary review of The University of Texas M D Anderson Cancer Center experience","volume":"110","author":"Kassouf","year":"2007","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10147-004-0457-6","article-title":"Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: A review of etiological features, natural history, and management","volume":"10","author":"Zaghloul","year":"2005","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13149-017-0547-4","article-title":"Schistosomose urog\u00e9nitale et cancer","volume":"110","author":"Berry","year":"2017","journal-title":"Bull. Soci\u00e9t\u00e9 Pathol. Exot."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.aju.2016.07.001","article-title":"Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches","volume":"14","author":"Martin","year":"2016","journal-title":"Arab. J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ng, K. (2022). The Etiology of Bladder Cancer, Exon Publications.","DOI":"10.36255\/exon-publications-urologic-cancers-etiology-bladder-cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-8-19","article-title":"Schistosomiasis and urinary bladder cancer in North Western Tanzania: A retrospective review of 185 patients","volume":"8","author":"Rambau","year":"2013","journal-title":"Infect. Agents Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/aam.aam_48_17","article-title":"A review of bladder cancer in Sub-Saharan Africa: A different disease, with a distinct presentation, assessment, and treatment","volume":"17","author":"Bowa","year":"2018","journal-title":"Ann. Afr. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40794-022-00161-x","article-title":"Urinary bladder Schistosoma haematobium-related squamous cell carcinoma: A report of two fatal cases and literature review","volume":"8","author":"Efared","year":"2022","journal-title":"Trop. Dis. Travel. Med. Vaccines"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-011-0751-7","article-title":"Urologic complications of genitourinary schistosomiasis","volume":"30","author":"Khalaf","year":"2012","journal-title":"World J. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1464-4096.2001.138.138.x","article-title":"Bilharziasis of the genitourinary tract","volume":"89","author":"Ghoneim","year":"2002","journal-title":"BJU Int."},{"key":"ref_20","first-page":"32.e11","article-title":"Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: A contemporary review with focus on nonbilharzial squamous cell carcinoma","volume":"32","author":"Rausch","year":"2014","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/1097-0142(19811215)48:12<2643::AID-CNCR2820481216>3.0.CO;2-C","article-title":"The impact of schistosomiasis on the pathology of bladder carcinoma","volume":"48","author":"Mokhtar","year":"1981","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12301-008-0011-2","article-title":"Pathologic pattern of invasive bladder carcinoma: Impact of bilharziasis","volume":"14","author":"Khalaf","year":"2008","journal-title":"Afr. J. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.17159\/sajs.2015\/20140427","article-title":"A review of the control of schistosomiasis in South Africa","volume":"111","author":"Magaisa","year":"2015","journal-title":"South. Afr. J. Sci."},{"key":"ref_24","first-page":"158","article-title":"Bilharziasis and bladder cancer: A time trend analysis of 9843 patients","volume":"19","author":"Gouda","year":"2007","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sokolow, S., Wood, C., Jones, I., Swartz, S., Lopez, M., Hsieh, M., Lafferty, K., Kuris, A., Rickards, C., and De Leo, G. (2016). Global Assessment of Schistosomiasis Control Over the Past Century Shows Targeting the Snail Intermediate Host Works Best. PLoS Neglected Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004794"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/551S46a","article-title":"Egypt: The flatworm\u2019s revenge","volume":"551","author":"Sarant","year":"2017","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1179\/2047773214Y.0000000149","article-title":"Water-based interventions for schistosomiasis control","volume":"108","year":"2014","journal-title":"Pathog. Glob. Health"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"King, C., and Bertsch, D. (2015). Historical Perspective: Snail Control to Prevent Schistosomiasis. PLoS Neglected Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003657"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s43066-024-00339-2","article-title":"Strategies and achievements in controlling and eliminating schistosomiasis from Egypt","volume":"14","author":"Sheemy","year":"2024","journal-title":"Egypt. Liver J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1079\/JOH2005307","article-title":"Towards control of schistosomiasis in sub-Saharan Africa","volume":"79","author":"Southgate","year":"2024","journal-title":"J. Helminthol."},{"key":"ref_31","unstructured":"World Health Organization (2013). Regional Strategic Plan for Neglected Tropical Diseases in the African Region 2014\u20132020, World Health Organization Regional Office for Africa."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Aula, O., McManus, D., Jones, M., and Gordon, C. (2021). Schistosomiasis with a Focus on Africa. Trop. Med. Infect. Dis., 6.","DOI":"10.3390\/tropicalmed6030109"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clgc.2020.06.004","article-title":"Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?","volume":"19","author":"Speir","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euf.2021.04.005","article-title":"Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy","volume":"8","author":"Lonati","year":"2022","journal-title":"Eur. Urol. Focus."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0022-5347(01)66118-4","article-title":"Bladder squamous cell carcinomas express psoriasin and externalize it to the urine","volume":"155","author":"Celis","year":"1996","journal-title":"J. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.humpath.2003.10.006","article-title":"Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: Frequency and prognostic significance of p53, BCL-2, HER2\/neu, and proliferation (MIB-1)","volume":"35","author":"Badr","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1464-410X.1997.30717.x","article-title":"Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder","volume":"79","author":"Chaudhary","year":"2003","journal-title":"Br. J. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1464-410X.1982.tb13580.x","article-title":"Squamous cell carcinoma of bladder. A review of 114 patients","volume":"54","author":"Rundle","year":"1982","journal-title":"Br. J. Urol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000020105","article-title":"Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases","volume":"37","author":"Serretta","year":"2000","journal-title":"Eur. Urol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0022-5347(01)64687-1","article-title":"Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder","volume":"157","author":"Navon","year":"1997","journal-title":"J. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0022-5347(01)64688-3","article-title":"The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients","volume":"157","author":"Stonehill","year":"1997","journal-title":"J. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1464-410X.2004.04588.x","article-title":"Squamous cell carcinoma of the bladder: Pathology, diagnosis and treatment","volume":"93","author":"Shokeir","year":"2004","journal-title":"BJU Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1308\/rcsann.2016.0343","article-title":"Risk factors for development of primary bladder squamous cell carcinoma","volume":"99","author":"Manley","year":"2017","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International Variations in Bladder Cancer Incidence and Mortality","volume":"66","author":"Chavan","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/03008880802285032","article-title":"The global burden of urinary bladder cancer","volume":"42","author":"Parkin","year":"2010","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.juro.2018.10.006","article-title":"Robotic Assisted Radical Cystectomy vs Open Radical Cystectomy: Systematic Review and Meta-Analysis","volume":"201","author":"Sathianathen","year":"2019","journal-title":"J. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Tang, K., Li, H., Xia, D., Hu, Z., Zhuang, Q., Liu, J., Xu, H., and Ye, Z. (2014). Laparoscopic versus Open Radical Cystectomy in Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Studies. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095667"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejso.2020.05.006","article-title":"Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder","volume":"47","author":"Deuker","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/j.clgc.2016.10.007","article-title":"Squamous cell carcinoma of the bladder: A SEER database analysis","volume":"15","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_50","first-page":"199","article-title":"Epidermoid carcinoma of the bladder. Apropos of 14 cases","volume":"31","author":"Debbagh","year":"1997","journal-title":"Ann. Urol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00345-015-1729-7","article-title":"Open radical cystectomy: Still the gold standard for muscle invasive bladder cancer","volume":"34","author":"Kiss","year":"2016","journal-title":"World J. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.ju.0000086828.26001.ca","article-title":"Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage","volume":"170","author":"Chang","year":"2003","journal-title":"J. Urol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/cncr.32048","article-title":"Delays in radical cystectomy for muscle-invasive bladder cancer","volume":"125","author":"Chu","year":"2019","journal-title":"Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","article-title":"Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes","volume":"2","author":"Boeri","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/j.clgc.2020.01.007","article-title":"Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study","volume":"18","author":"Bandini","year":"2020","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.clgc.2014.04.002","article-title":"Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Invasive Transitional and Squamous Cell Carcinoma of the Bladder: Effect on Survival and Bladder Preservation","volume":"12","author":"Khaled","year":"2014","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_57","first-page":"e317","article-title":"The impact of squamous histology on survival in patients with muscle-invasive bladder cancer","volume":"37","author":"Matulay","year":"2019","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.urology.2006.10.029","article-title":"Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract","volume":"69","author":"Galsky","year":"2007","journal-title":"Urology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/jco.2016.34.2_suppl.356","article-title":"A randomized clinical trial comparing adjuvant radiation versus chemo-RT versus chemotherapy alone after radical cystectomy for locally advanced bladder cancer","volume":"34","author":"Zaghloul","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2017.0156","article-title":"Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Spiess","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1016\/j.clgc.2017.07.008","article-title":"Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder","volume":"15","author":"Minato","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s10147-019-01409-x","article-title":"Squamous cell carcinoma of the bladder: Poor response to neoadjuvant chemotherapy","volume":"24","author":"Dotson","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_63","first-page":"3865","article-title":"The Outcome of Patients with Advanced Pure Squamous or Mixed Squamous and Transitional Urothelial Carcinomas Following Platinum-based Chemotherapy","volume":"26","author":"Kastritis","year":"2006","journal-title":"Anticancer. Res."},{"key":"ref_64","first-page":"4465","article-title":"Effect of Maintenance Chemotherapy with Gemcitabine and Paclitaxel on Recurrent Squamous Cell Carcinoma of the Bladder: A Case Report","volume":"31","author":"Miyata","year":"2011","journal-title":"Anticancer. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.2001.19.9.2527","article-title":"Combination Paclitaxel, Carboplatin, and Gemcitabine Is an Active Treatment for Advanced Urothelial Cancer","volume":"19","author":"Hussain","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/02841868409135983","article-title":"Radiation Management of Squamous Cell Carcinoma of the Bladder","volume":"23","author":"Prempree","year":"1984","journal-title":"Acta Radiol. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0360-3016(86)90377-9","article-title":"Radiotherapy for squamous carcinoma of the urinary bladder","volume":"12","author":"Quilty","year":"1986","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_68","first-page":"854","article-title":"Radiotherapy in muscle-invasive bladder cancer: The latest research progress and clinical application","volume":"5","author":"Zhang","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_69","first-page":"115","article-title":"Outcome of three-dimensional conformal radiotherapy for 109 patients with bladder cancer","volume":"18","author":"Shen","year":"2009","journal-title":"Chin. J. Radiat. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1200\/JCO.2020.38.6_suppl.524","article-title":"Prospective trial of adjuvant therapy after radical cystectomy for locally advanced bladder cancer: Analysis of the squamous cell carcinoma subgroup","volume":"38","author":"Zaghloul","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/153303460600500501","article-title":"Intensity Modulated Radiation Therapy: A Review of Current Practice and Future Directions","volume":"5","author":"Sanghani","year":"2006","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-717X-6-75","article-title":"Intensity modulated radiotherapy for elderly bladder cancer patients","volume":"6","author":"Hsieh","year":"2011","journal-title":"Radiat. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2009.08.015","article-title":"Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?","volume":"93","author":"Guckenberger","year":"2009","journal-title":"Radiother. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1748-717X-7-111","article-title":"A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer","volume":"7","author":"Foroudi","year":"2012","journal-title":"Radiat. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Sobhani, N., Tardiel-Cyril, D.R., Davtyan, A., Generali, D., Roudi, R., and Li, Y. (2021). CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers, 13.","DOI":"10.20944\/preprints202102.0150.v1"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00280-019-03800-x","article-title":"Disruption of CTLA-4 expression on peripheral blood CD8\u2009+\u2009T cell enhances anti-tumor efficacy in bladder cancer","volume":"83","author":"Zhang","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/eji.201646583","article-title":"Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer","volume":"47","author":"Sandin","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1634\/theoncologist.2012-0391","article-title":"Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma","volume":"18","author":"Luke","year":"2013","journal-title":"Oncologist"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/172460080902400103","article-title":"Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder","volume":"24","author":"Boulalas","year":"2009","journal-title":"Int. J. Biol. Markers"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.euo.2019.02.004","article-title":"Circulating tumor DNA alterations in advanced urothelial carcinoma and association with clinical outcomes: A pilot study","volume":"3","author":"Grivas","year":"2020","journal-title":"Eur. Urol. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/169\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:24:18Z","timestamp":1759919058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":81,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["cancers17020169"],"URL":"https:\/\/doi.org\/10.3390\/cancers17020169","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]}}}